Image

Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX

Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX

Recruiting
16-35 years
Male
Phase N/A

Powered by AI

Overview

The study is a two-phase observational study that assess multiple aspects of study and young men who have sex with men (YMSM).

Phase I of the study will be a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) to acquire information necessary for developing a more extensive study on the same matter.

Phase II of the study will be a prospective cohort study using a quantitative data collection.

Findings from phase I will guide the development of phase II which consist of a larger number of YMSM, important baseline and follow-up questionnaires and comorbidities assessments, sexually transmitted infections testing, and integration to care.

This protocol exclusively addresses the phase I of the study.

Once the phase I findings are finalized, the principal investigator will submit the phase II to the IRB of the Faculty of Medicine, Chulalongkorn University.

Eligibility

Inclusion Criteria:

Group 1A: Current chemsex users

  1. Men who have sex with men
  2. Aged 16-35 years
  3. Able to communicate in Thai fluently
  4. Current chemsex users
  5. Provide informed consent

Inclusion Criteria:

Group 1B: Former chemsex users (discontinued ≥90 days)

  1. Men who have sex with men
  2. Aged 16-35 years
  3. Able to communicate in Thai fluently
  4. Former chemsex users (discontinued ≥90 days)
  5. Provide informed consent

Exclusion Criteria:

No exclusion criteria for all groups of participants

Study details
    ChemSex Users for YMSM
    ChemSex Users

NCT05559658

Institute of HIV Research and Innovation Foundation, Thailand

1 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.